NCT Number: NCT01985828
Phase: Not Applicable
Trial Summary: The primary objective of this study is to document the effectiveness of Cyberknife stereotactic body radiotherapy (SBRT) in the treatment of intermediate and high-risk localized pr – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Advocate Health Care
Acronym:
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives